Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
Ticker Information
Ticker
ASBPCompany Name
ASPIRE BIOPHARMA HOLDINGS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQASPIRE BIOPHARMA HOLDINGS INC - Price to Earnings Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ASBP - P/E Historical data
| Date | Market Capitalization | Net Income Common Stock | Price to Earnings |
|---|---|---|---|
| 6/30/2025 | $ 19.76M | $ -18.9M | 0 |
| 3/31/2025 | $ 11.79M | $ -17.53M | 0 |
| 12/31/2024 | $ 24.94M | $ -1.31M | 0 |
| 9/30/2024 | $ 90.02M | $ -3.76M | 0 |
| 6/30/2024 | $ 87.2M | $ -3.29M | 0 |
| 3/31/2024 | $ 88.29M | $ -875.46K | 0 |
| 12/31/2023 | $ 99.35M | $ 4.46M | 22.26 |
| 9/30/2023 | $ 98.09M | $ 6.85M | 14.33 |
| 6/30/2023 | $ 94.86M | $ 7.99M | 11.87 |
| 3/31/2023 | $ 378.42M | $ 6.3M | 60.06 |
Key Performance Insights, Last 5 Years
- ASPIRE BIOPHARMA HOLDINGS INC's latest trailing twelve months (TTM) P/E stands at 0.
- Over the past 5 years, ASPIRE BIOPHARMA HOLDINGS INC's average P/E has been 44.23.
- The median P/E for ASPIRE BIOPHARMA HOLDINGS INC during this period was 22.26
- ASPIRE BIOPHARMA HOLDINGS INC reached its highest P/E over the past 5 years at 112.65.
- The lowest P/E recorded by ASPIRE BIOPHARMA HOLDINGS INC in the same timeframe 11.87
Similar metrics to P/E:
- Earnings Yield - [Calculation] The Earnings Yield, also known as the inverse of the PE ratio [PE], expresses a company’s earnings [NetIncCmn] as a percentage of [MarketCap].
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
Definition of Price to Earnings
[Calculation] Measures a company’s [MarketCap] in relation to its Net Income [NetIncCmn]. A high P/E ratio indicates that investors anticipate greater future earnings growth compared to companies with a lower P/E.Market Cap / Net Inc. Cmn.
(=) P/E P/E for ASPIRE BIOPHARMA HOLDINGS INC is calculated as follows: Market Cap [ $ 0 ] / Net Inc. Cmn. [ $ -25.48K ]
(=) P/E [ 0 ] ASBP - Price to Earnings, Last 5 years
11.87
Minimum
Jun 30, 2023
112.65
Maximum
Dec 31, 2022
44.23
Average
22.26
Median
P/E Benchmark AnalysisMarket
The chart above depicts the distribution of P/E for companies in the Total Stock Market. The average P/E of the companies is 22.52 with a standard deviation of 13.95.
The following table provides additional summary stats:
P/E in the Market:
| filtered constituents | 2.07K |
|---|---|
| min | 0.13 |
| max | 70.11 |
| average | 22.52 |
| median | 18.89 |
| std | 13.95 |